WP
KALA icon

Woodline Partners’s KALA BIO KALA Stock Holding History

Woodline Partners’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,483
Closed -$125K – 1106
2025
Q4 		$125K Sell
4,483
-466
-9% -$20.9K ﹤0.01% 1007
2025
Q3 		$379K Sell
4,949
-1,054
-18% -$523K ﹤0.01% 852
2025
Q2 		$1.43M Buy
6,003
+828
+16% +$162K 0.01% 765
2025
Q1 		$1.48M Buy
+5,175
New +$1.96M 0.01% 717

Other funds holding KALA

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Woodline Partners's KALA Position: Q1 2026 in Review

Woodline Partners sold out of KALA BIO (KALA) in Q1 2026, closing a stake of 4,483 shares — an estimated $125K sold.

Woodline Partners first reported a position in KALA in Q1 2025 and held it in 4 quarters. The position peaked at $1.48M in Q1 2025. 28 funds tracked by Wall St. Rank hold KALA as of Q1 2026.

  • Woodline Partners reported no remaining KALA BIO position as of Q1 2026 after selling out during the quarter.
  • Woodline Partners sold 4,483 KALA BIO shares in Q1 2026, an estimated $125K.
  • Woodline Partners first reported a position in KALA BIO in Q1 2025 and held it in 4 quarters.
  • Woodline Partners's KALA BIO position peaked at $1.48M in Q1 2025.
  • 28 funds tracked by Wall St. Rank held KALA BIO as of Q1 2026.

Based on Woodline Partners's 13F filing for Q1 2026, filed 15 May 2026.